Results 241 to 250 of about 2,636,203 (317)

Left atrial function in uraemic patients: Four‐dimensional automatic left atrial quantitative technology study

ESC Heart Failure, Volume 12, Issue 2, Page 1316-1325, April 2025.
Abstract Objective This study aimed to evaluate the utility of left atrial volume and function in uraemic patients using four‐dimensional automatic left atrial quantification (4D auto LAQ) technology. Methods Thirty‐four undialysed uraemic patients (U‐ND group), 60 dialysed uraemic patients (U‐D group), and 32 healthy volunteers (N group) were enrolled
Bing Li, Meihua Chen, Xuning Huang
wiley   +1 more source

Assessment of Cognitive Function via Biomarkers in Japanese Patients With Chronic Heart Failure Treated With Angiotensin-Receptor-Neprilysin Inhibitor. [PDF]

Circ Rep
Kogure M, Kitani-Morii F, Kitani T, Oishi M, Shiraishi H, Tatebe H, Matoba S, Tokuda T, Kasai T.   +8 more
europepmc   +1 more source

Prognostic impact of iron deficiency in new‐onset chronic heart failure: Danish Heart Failure Registry insights

ESC Heart Failure, Volume 12, Issue 2, Page 1346-1357, April 2025.
Abstract Aims Iron deficiency (ID) is prevalent in chronic heart failure (HF) but lacks a consensus definition. This study evaluates the prevalence and the prognostic impact of ID using different criteria on all‐cause and cardiovascular mortality, as well as first hospitalization for HF in patients with new‐onset chronic HF.
Abdullahi Ahmed Mohamed, Daniel Mølager Christensen, Milan Mohammad, Christian Torp‐Pedersen, Lars Køber, Emil Loldrup Fosbøl, Tor Biering‐Sørensen, Morten Lock Hansen, Mariam Elmegaard Malik, Nina Nouhravesh, Charlotte Anderrson, Morten Schou, Gunnar Gislason   +12 more
wiley   +1 more source

A Delphi consensus project to capture experts' opinion on hyperkalaemia management across the cardiorenal spectrum

ESC Heart Failure, Volume 12, Issue 2, Page 1132-1140, April 2025.
Abstract The main purpose of this project was to capture experts' opinion on hyperkalaemia management and form best practice recommendations for cardiorenal patients in Greece. A steering committee of nephrologists and cardiologists developed 37 statements. An online questionnaire completed by 32 experts in cardiorenal management in Greece.
Christina Chrysohoou, Maria Marketou, Maria Aktsiali, Ioannis Griveas   +3 more
wiley   +1 more source

Angiotensin-(1–7) is an endogenous ligand for the G protein-coupled receptor Mas

Proceedings of the National Academy of Sciences of the United States of America, 2003
R. Santos, A. C. S. e Silva, C. Maric, Denise M. R. Silva, Raquel P. Machado, I. de Buhr, S. Heringer-walther, S. Pinheiro, M. T. Lopes, M. Bader, E. P. Mendes, V. S. Lemos, M. Campagnole-Santos, H. Schultheiss, R. Speth, T. Walther   +15 more
semanticscholar   +1 more source

FDG PET/CT imaging and circulating biomarkers of inflammation in desmoplakin cardiomyopathy

ESC Heart Failure, Volume 12, Issue 2, Page 1485-1489, April 2025.
Abstract Aims Inflammation has been implicated in the pathogenesis of desmoplakin (DSP) cardiomyopathy, and retrospective studies have described abnormal myocardial fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) findings in symptomatic patients eventually diagnosed with DSP cardiomyopathy.
Sanjay Divakaran, Vinay Randhawa, Usman A. Tahir, Matthew Robertson, Anam A. Waheed, Anna Perillo, Leanne Barrett, Ron Blankstein, Mark W. Feinberg, Marcelo F. Di Carli, Neal K. Lakdawala   +10 more
wiley   +1 more source

Angiotensin Receptor Blockade Does Not Decrease Synthetic Angiotensin II (Giapreza^®) Effectiveness in Perioperative Hypotension Surrounding Kidney Transplant. [PDF]

Biomedicines
Pettit N, Benken J, Valdepeñas B, Gandhi N, Alyousef R, Benken S.   +5 more
europepmc   +1 more source

Effects of compound 21, a non‑peptide angiotensin II type 2 receptor agonist, on general anesthesia‑induced cerebral injury in neonatal rats

, 2018
Jun Yong, Yan Li, Jing Wang, Hong‐Mei Xiao, Qingfan Zeng   +4 more
openalex   +2 more sources

The Comparative Efficacy and Safety of the Angiotensin Receptor Blockers in the Management of Hypertension and Other Cardiovascular Diseases

Drug Safety, 2014
Abraham Hm, White Cm, W. White
semanticscholar   +1 more source

Lack of weight gain after angiotensin AT1 receptor blockade in diet‐induced obesity is partly mediated by an angiotensin‐(1–7)/Mas‐dependent pathway

British Journal of Pharmacology, 2015
Johanna Schuchard, Martina Winkler, Ines Stölting, Franziska Schuster, F. Vogt, J. Barkhausen, C. Thorns, R. Santos, M. Bader, W. Raasch   +9 more
semanticscholar   +1 more source